Joseph F. Bohan
Corporate Officer/Principal bei SciDose LLC
Profil
Joseph F.
Bohan III has been a Director of Bioject Medical Technologies, Inc. since August 2005.
Mr. Bohan founded SciDose LLC in January 2006.
He was Vice President of Worldwide Business Development for Nektar Therapeutics from 2001 to January 2006.
From 1999 to 2000, Mr. Bohan was Vice President of Business Development for Bradford Particle Design.
From 1989 to 1998, he was President and Chief Executive Officer of Amherst Process Instruments, Inc.
Aktive Positionen von Joseph F. Bohan
Unternehmen | Position | Beginn |
---|---|---|
SciDose LLC | Corporate Officer/Principal | 01.01.2006 |
Ehemalige bekannte Positionen von Joseph F. Bohan
Unternehmen | Position | Ende |
---|---|---|
BIOJECT MEDICAL TECHNOLOGIES INC. | Direktor/Vorstandsmitglied | 18.12.2009 |
NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01.01.2006 |
Nektar Therapeutics UK Ltd.
Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Corporate Officer/Principal | 01.01.2000 |
Amherst Process Instruments, Inc.
Amherst Process Instruments, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of TSI, Inc. (Minnesota), Amherst Process Instruments, Inc. develops and makes powder flow and sizing equipment for the pharmaceutical industry. The company is based in Hadley, MA. Amherst Process Instruments was acquired by TSI, Inc. (Minnesota) on October 15, 1998. | Präsident | 01.01.1998 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
Private Unternehmen | 4 |
---|---|
Bioject Medical Technologies, Inc.
Bioject Medical Technologies, Inc. Medical SpecialtiesHealth Technology Bioject Medical Technologies, Inc. develops and manufactures needle-free injection therapy systems. Its products include Biojector 2000, Needle Free Injection System, ZetaJet, Drug Reconstitution System, and Needle-Free Vial Adapter. The company was founded in 1985 and is headquartered in Tigard, OR. | Health Technology |
Amherst Process Instruments, Inc.
Amherst Process Instruments, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of TSI, Inc. (Minnesota), Amherst Process Instruments, Inc. develops and makes powder flow and sizing equipment for the pharmaceutical industry. The company is based in Hadley, MA. Amherst Process Instruments was acquired by TSI, Inc. (Minnesota) on October 15, 1998. | Electronic Technology |
Nektar Therapeutics UK Ltd.
Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Health Technology |
SciDose LLC |